BEUDAMED
    FDA Adverse Event Injury Summary report: N

    132CM CEREGLIDE 71 CATHETER

    MDR report key: 19691125 · Received July 8, 2024

    Report

    Report Number
    3007628272-2024-00037
    Event Type
    Injury
    Date Received
    July 8, 2024
    Report Date
    August 7, 2024
    Manufacturer
    CERENOVUS, INC.
    Product Code
    QJP
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    PRODUCT COMPLAINT # (B)(4). UPDATED SECTIONS ON THIS MED WATCH: B4, B5, D2B, G3, G6, H2 AND H11. SECTION B5: ADDITIONAL INFORMATION WAS RECEIVED ON 29-JUL-2024. SUMMARY: PER THE LIMITED INFORMATION RECEIVED, THERE WERE NO ALLEGED PRODUCT MALFUNCTION WITH THE USED CERENOVUS PRODUCTS. THE PATIENT IS AN 83-YEAR-OLD FEMALE. REGARDING ANY RESIDUAL SYMPTOMS, IT WAS SAID THE PATIENT¿S PARALYSIS REMAINED. SECTION D2B: PROCODE IS NRY/QJP (CORRECTED DATA) D4: UDI: AS THE LOT NUMBER FOR THE DEVICE INVOLVED IN THE EVENT WAS NOT PROVIDED, THE FULL UDI IS CURRENTLY NOT AVAILABLE. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF NEW FACTS ARISE WHICH MATERIALLY ALTER INFORMATION SUBMITTED IN A PREVIOUS MDR REPORT.

    Additional Manufacturer Narrative · 0

    PRODUCT COMPLAINT # (B)(4). INFORMATION REGARDING PATIENT WEIGHT, HEIGHT, MEDICAL HISTORY, RACE, AND ETHNICITY WAS NOT REPORTED. SECTION B3 ¿ DATE OF EVENT: THE DATE OF THE EVENT WAS NOT REPORTED. SECTION D.: THE PRODUCT LOT NUMBER WAS NOT AVAILABLE / NOT REPORTED. THE EXPIRATION DATE OF THE DEVICE IS NOT KNOWN. SECTION E1. INITIAL REPORTER PHONE: (B)(6). . THE DEVICE WAS DISCARDED; THEREFORE, NO FURTHER INVESTIGATION CAN BE PERFORMED. THE LOT NUMBER IS NOT KNOWN; THEREFORE, A DEVICE HISTORY RECORD REVIEW CANNOT BE COMPLETED. A THROMBOEMBOLISM IS A KNOWN POTENTIAL COMPLICATION ASSOCIATED WITH THE USE OF THE EMBOTRAP III AND CEREGLIDE71 CATHETER AND IS LISTED IN INSTRUCTIONS FOR USE (IFU) AS SUCH FOR BOTH DEVICES. THERE WERE NO ALLEGED QUALITY ISSUES RELATED TO THE USED DEVICES, AS THE DEVICES PERFORMED AS INTENDED. PER THE EVENT DESCRIPTION, A ¿FILLING DEFECT WAS FOUND AT ANTERIOR CEREBRAL ARTERY.¿ A FILLING DEFECT IS A GENERAL TERM USED TO REFER TO ANY ABNORMALITY ON AN IMAGING STUDY WHICH DISRUPTS THE NORMAL OPACIFICATION (FILLING) OF A CAVITY OR LUMEN. BASED ON THE GIVEN INTERVENTION OF USING THE VECTA46 INTERMEDIATE CATHETER TO ACHIEVE FULL RECANALIZATION, THE ¿FILLING DEFECT¿ IT IS CLINICALLY UNDERSTOOD AS REFERRING TO A THROMBOEMBOLISM. SINCE A THROMBOEMBOLISM IS CONSIDERED A SERIOUS INJURY, AND THE EVENT REQUIRED THE ADDITIONAL SURGICAL INTERVENTION OF ANOTHER RETRIEVAL ATTEMPT AND RESULTED IN A CLINICALLY SIGNIFICANT PROCEDURAL DELAY, THIS EVENT DOES MEET US FDA REPORTING CRITERIA UNDER 21 CFR 803 WITH A CLASSIFICATION OF ¿SERIOUS INJURY.¿ THE FILE WILL BE RE-REVIEWED IF ADDITIONAL INFORMATION IS RECEIVED AT A LATER DATE. AS PART OF THE POST MARKET SURVEILLANCE PROGRAM, INFORMATION FROM THIS COMPLAINT IS TRENDED TO IDENTIFY STATISTICAL SIGNALS FOR CONSIDERATION OF FURTHER CORRECTION ACTION. SINCE THERE WAS NO EVIDENCE TO SUGGEST THE EVENT WAS RELATED TO A MANUFACTURING OR DESIGN ISSUE, NO CORRECTIVE ACTIONS WILL BE TAKEN AT THIS TIME. MISSING INFORMATION FROM THIS REPORT IS IDENTIFIED AS BLANK; THIS INFORMATION WAS NOT PROVIDED IN THE REPORTED EVENT OR AVAILABLE AT THE TIME OF REPORT SUBMISSION. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803 (AND/OR PART 4, AS APPLICABLE). THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY CERENOVUS, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, CERENOVUS, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

    Description of Event or Problem · 0

    IT WAS REPORTED, VIA A PERSONAL INTERACTION, THAT A 132CM CEREGLIDE 71 CATHETER (NIC71132C/LOT # UNKNOWN) AND AN EMBOTRAP III 6.5 MM X 45 MM (ET309645/LOT # UNKNOWN), WERE USED FOR A MECHANICAL THROMBECTOMY OF LEFT INTERNAL CAROTID ARTERY (ICA) OCCLUSION FOR ACUTE CEREBRAL INFARCTION. TWO PASSES WERE MADE BY USING EMBOTRAP AND THE CEREGLIDE 71, AND RECANALIZATION WAS ACHIEVED. HOWEVER, AT THIS TIME THE USER REPORTED A ¿FILLING DEFECT¿ WAS FOUND AT THE ANTERIOR CEREBRAL ARTERY. A DIRECT ASPIRATION, FIRST PASS TECHNIQUE (ADAPT) WAS PERFORMED BY USING VECTA46 INTERMEDIATE CATHETER (STRYKER) AND FULL RECANALIZATION WAS ACHIEVED. THE USER REPORTED EXTENSIVE ISCHEMIC FOCI WERE OBSERVED BECAUSE IT TOOK A LONG TIME FROM ONSET TO COMPLETION OF THE PROCEDURE. THE EVENT WAS REPORTED AS SUCH, ¿THE PROCEDURE WAS A MECHANICAL THROMBECTOMY OF LEFT INTERNAL CAROTID ARTERY OCCLUSION FOR ACUTE CEREBRAL INFARCTION. 2 PASSES WERE MADE BY USING EMBOTRAP 6.5×45 AND THE CEREGLIDE 71, AND RECANALIZATION WAS ACHIEVED. FILLING DEFECT WAS FOUND AT ANTERIOR CEREBRAL ARTERY, SO ADAPT WAS PERFORMED BY USING VECTA46 AND FULL RECANALIZATION WAS ACHIEVED. THE FULLY RECANALIZATION WAS ACHIEVED 90 MINUTES AFTER THE PUNCTURE AND NO SYMPTOMATIC INTRACEREBRAL HEMORRHAGE WAS FOUND. HOWEVER, EXTENSIVE ISCHEMIC FOCI WERE OBSERVED BECAUSE IT TOOK A LONG TIME FROM ONSET TO COMPLETION OF THE PROCEDURE. POST-PROCEDURE CHANGES IN THE PATIENT: THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON MAY 24 WITH MRS 5. AFTER 3 MONTHS, MRS REMAINED 5. CONTINUOUS FLUSH WAS UNKNOWN. OTHER CONCOMITANT DEVICES WERE TRAK MICROCATHETER, OPTIMO 8FR GUIDING CATHETER. THE PATIENT INITIALLY PRESENTED WITH SYMPTOMS OF APHASIA AND RIGHT-SIDED PARALYSIS. NIHSS: 25, ASPECTS-DWI: 3.¿ NO FURTHER INFORMATION IS AVAILABLE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    869658 132CM CEREGLIDE 71 CATHETER CATHETER, ASPIRATION CATHETER QJP CERENOVUS, INC.

    Patients

    Seq Age Sex Outcome Treatment
    1 83 YR Female Life Threatening| R AXS VECTA® 46 INTERMEDIATE CATHETER (STRYKER)| EMBOTRAP III 6.5 MM X 45 MM| OPTIMO¿ BALLOON GUIDE CATHETER (TOKAI MEDICAL)| TRAK¿ 21 MICROCATHETER (STRYKER)